<p>NEW YORK (Dow Jones/AP) -- Meridian Medical Technologies Inc.'s shares rose Monday after the U.S. Department of Defense renewed a three-year contract for auto-injectors that provide soldiers with antidotes to nerve agents.</p>
<p>Shares of Meridian Medical, a Columbia, Md., medical technology company, closed Monday at $30.68, up $5.17, or 20 percent, on the Nasdaq Stock Market.</p>
